Helminth-induced Immunomodulation Therapy (HINT) in Relapsing-remitting Multiple Sclerosis
NCT00645749
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
BIOLOGICAL:
Helminth ova
Sponsor
University of Wisconsin, Madison
Collaborators
[object Object]